[HTML][HTML] Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
Q Wu, W Qian, X Sun, S Jiang - Journal of hematology & oncology, 2022 - Springer
Abstract The United States Food and Drug Administration (US FDA) has always been a
forerunner in drug evaluation and supervision. Over the past 31 years, 1050 drugs …
forerunner in drug evaluation and supervision. Over the past 31 years, 1050 drugs …
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
Q Wu, W Qian, X Sun, S Jiang - Journal of Hematology & …, 2022 - search.proquest.com
Abstract The United States Food and Drug Administration (US FDA) has always been a
forerunner in drug evaluation and supervision. Over the past 31 years, 1050 drugs …
forerunner in drug evaluation and supervision. Over the past 31 years, 1050 drugs …
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
Q Wu, W Qian, X Sun, S Jiang - Journal of hematology …, 2022 - pubmed.ncbi.nlm.nih.gov
The United States Food and Drug Administration (US FDA) has always been a forerunner in
drug evaluation and supervision. Over the past 31 years, 1050 drugs (excluding vaccines …
drug evaluation and supervision. Over the past 31 years, 1050 drugs (excluding vaccines …
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021.
Q Wu, W Qian, X Sun, S Jiang - Journal of Hematology & …, 2022 - search.ebscohost.com
Abstract The United States Food and Drug Administration (US FDA) has always been a
forerunner in drug evaluation and supervision. Over the past 31 years, 1050 drugs …
forerunner in drug evaluation and supervision. Over the past 31 years, 1050 drugs …
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021.
Q Wu, W Qian, X Sun, S Jiang - Journal of Hematology & Oncology, 2022 - europepmc.org
Abstract The United States Food and Drug Administration (US FDA) has always been a
forerunner in drug evaluation and supervision. Over the past 31 years, 1050 drugs …
forerunner in drug evaluation and supervision. Over the past 31 years, 1050 drugs …
[HTML][HTML] Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
Q Wu, W Qian, X Sun, S Jiang - … of Hematology & …, 2022 - jhoonline.biomedcentral.com
The United States Food and Drug Administration (US FDA) has always been a forerunner in
drug evaluation and supervision. Over the past 31 years, 1050 drugs (excluding vaccines …
drug evaluation and supervision. Over the past 31 years, 1050 drugs (excluding vaccines …
[HTML][HTML] Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
Q Wu, W Qian, X Sun, S Jiang - Journal of Hematology & Oncology, 2022 - ncbi.nlm.nih.gov
Abstract The United States Food and Drug Administration (US FDA) has always been a
forerunner in drug evaluation and supervision. Over the past 31 years, 1050 drugs …
forerunner in drug evaluation and supervision. Over the past 31 years, 1050 drugs …
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
Q Wu, W Qian, X Sun, S Jiang - Journal of Hematology & Oncology, 2022 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> The United States Food and Drug
Administration (US FDA) has always been a forerunner in drug evaluation and supervision …
Administration (US FDA) has always been a forerunner in drug evaluation and supervision …
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021.
Q Wu, W Qian, X Sun, S Jiang - Journal of Hematology & Oncology, 2022 - europepmc.org
Abstract The United States Food and Drug Administration (US FDA) has always been a
forerunner in drug evaluation and supervision. Over the past 31 years, 1050 drugs …
forerunner in drug evaluation and supervision. Over the past 31 years, 1050 drugs …
[HTML][HTML] Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
Q Wu, W Qian, X Sun, S Jiang - … of Hematology & …, 2022 - jhoonline.biomedcentral.com
The United States Food and Drug Administration (US FDA) has always been a forerunner in
drug evaluation and supervision. Over the past 31 years, 1050 drugs (excluding vaccines …
drug evaluation and supervision. Over the past 31 years, 1050 drugs (excluding vaccines …